Scarica l'app Stockscreener
42.33
0.57%
0.24
Dopo l'orario di chiusura:
42.33
Precedente Chiudi:
$42.09
Aprire:
$42.22
Volume 24 ore:
947.97K
Relative Volume:
0.84
Capitalizzazione di mercato:
$9.41B
Reddito:
$1.94B
Utile/perdita netta:
$72.70M
Rapporto P/E:
29.19
EPS:
1.45
Flusso di cassa netto:
$405.21M
1 W Prestazione:
+0.57%
1M Prestazione:
+0.50%
6M Prestazione:
-5.98%
1 anno Prestazione:
+1.73%
Intervallo 1D:
$42.04
$42.48
Intervallo di 1 settimana:
$40.35
$42.48
Portata 52W:
$39.03
$47.44
Qiagen Nv Stock (QGEN) Company Profile
Nome
Qiagen Nv
Settore
Industria
Telefono
-
Indirizzo
-
Confronta QGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| QGEN | 42.33 | 9.41B | 1.94B | 72.70M | 405.21M | 1.45 |
| TMO | 516.10 | 196.16B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 235.05 | 167.17B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 132.06 | 37.94B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 197.60 | 35.86B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 418.55 | 34.27B | 3.84B | 866.24M | 792.60M | 9.80 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-12-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-09-12 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-23 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Aggiornamento | DZ Bank | Hold → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-10-14 | Iniziato | Redburn | Buy |
| 2021-07-14 | Downgrade | Kepler | Buy → Hold |
| 2021-06-03 | Iniziato | Goldman | Neutral |
| 2020-10-06 | Ripresa | BofA Securities | Buy |
| 2020-09-28 | Aggiornamento | Kepler | Hold → Buy |
| 2020-08-24 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-08-17 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Downgrade | Berenberg | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-12-26 | Ripresa | BofA/Merrill | Underperform |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-11-14 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Aggiornamento | Kepler | Reduce → Hold |
| 2019-10-17 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Downgrade | Kepler | Hold → Reduce |
| 2019-10-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
Mostra tutto
Qiagen Nv Borsa (QGEN) Ultime notizie
Massachusetts Financial Services Co. MA Sells 79,145 Shares of Qiagen (NYSE:QGEN) - MarketBeat
Jennison Associates LLC Boosts Holdings in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN NV : Jefferies is Neutral - Marketscreener.com
Qiagen (NYSE:QGEN) Stake Lowered by Nuance Investments LLC - MarketBeat
QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up - MSN
Analysts Set Qiagen (NYSE:QGEN) Price Target at $50.88 - MarketBeat
Qiagen (NYSE:QGEN) Shares Bought by Natixis Advisors LLC - MarketBeat
180,729 Shares in Qiagen (NYSE:QGEN) Purchased by Impax Asset Management Group plc - MarketBeat
QGEN Collaborates With McGill University Centre: Stock to Gain? - Yahoo Finance
Victory Capital Management Inc. Has $117.33 Million Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
What is William Blair's Estimate for Qiagen FY2024 Earnings? - MarketBeat
Crossmark Global Holdings Inc. Sells 12,133 Shares of Qiagen (NYSE:QGEN) - MarketBeat
Pharmahungary Group participates in ambitious EU EVEREST Project - European Biotechnology News
QIAGEN collaborates with McGill University to advance microbiome research - GlobeNewswire
QIAGEN Partners with McGill to Target $1.8B Microbiome Market in Major Research Deal | QGEN Stock News - StockTitan
Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock - Yahoo Finance
QIAGEN NV : UBS reiterates its Neutral rating - Marketscreener.com
Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook - Investing.com India
Earnings call: QIAGEN tops Q3 expectations, raises 2024 EPS outlook By Investing.com - Investing.com Australia
Qiagen Non-GAAP EPS of $0.46 beats by $0.02, revenue of $459M beats by $2.09M - MSN
Wellington Management Group LLP's Strategic Acquisition of Qiage - GuruFocus.com
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term - Yahoo Finance
Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - GuruFocus.com
Qiagen Reports Strong Q3 2024 Growth - TipRanks
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation? - Yahoo Finance
QIAGEN NV : Deutsche Bank reaffirms its Buy rating - Marketscreener.com
Qiagen Q3 24 Earnings Conference Call At 9:30 AM ET - Nasdaq
QIAGEN : Markets hailed the Q3 beat + the profitability upgrade - Marketscreener.com
QIAGEN NV : Receives a Buy rating from Berenberg - Marketscreener.com
Qiagen (NYSE:QGEN) Shares Sold by Van ECK Associates Corp - MarketBeat
Qiagen N : QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full year 2024 adjusted EPS outlook - Marketscreener.com
QIAGEN NV : UBS reaffirms its Neutral rating - Marketscreener.com
Qiagen N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Qiagen (QGEN) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
Diagnostics firm Qiagen reports rise in third-quarter revenue - Reuters
QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook - The Manila Times
QIAGEN Q3 Earnings Surge: Sales Hit $502M, Boosts 2024 EPS Outlook | QGEN Stock News - StockTitan
Qiagen NV (QGEN) Q3 2024: Everything You Need to Know Ahead of E - GuruFocus.com
FDA clears fourth Qiagen test in 2024 - BioWorld Online
Qiagen NV (QGEN) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel - Yahoo Finance
Qiagen (QGEN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics - GlobeNewswire
Qiagen Receives FDA Clearance Of Qiastat-Dx Meningitis/Encephalitis Panel To Support Emergency Diagnostics - XM
Forsta AP Fonden Sells 18,586 Shares of Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (QGEN) Set to Announce Earnings on Wednesday - MarketBeat
Raymond James & Associates Trims Position in Qiagen (NYSE:QGEN) - MarketBeat
Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire Inc.
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment - GlobeNewswire
Qiagen Nv Azioni (QGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):